Home › Duchenne Muscular Dystrophy › Illinois › Chicago
Duchenne Muscular Dystrophy clinical trials in Chicago, IL
5 studies for Duchenne Muscular Dystrophy are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD) - Non-Ambulatory Cohort
RecruitingPhase 1
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Once Weekly Infant Corticosteroid Trial for DMD
RecruitingPhase 4
- Lurie Children's Hospital of Chicago, Chicago
Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug Trials
RecruitingObservational study
- Lurie Children's, Chicago
A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)
RecruitingPhase 1/2
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
A Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular Dystrophy
RecruitingObservational study
- Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago
Duchenne Muscular Dystrophy trials in other cities
- Little Rock, AR7 studies
- Boston, MA5 studies
- Washington, DC5 studies
- Durham, NC5 studies
- Sacramento, CA5 studies
- Gainesville, FL5 studies
- Columbus, OH4 studies
- Nashville, TN4 studies
- Seattle, WA3 studies
- Portland, OR3 studies
- Mountain View, CA3 studies
- St. Louis, MO3 studies
Other studies in Chicago
- Non-Small Cell Lung Cancer61 studies
- Breast Cancer58 studies
- Cancer (all types)51 studies
- Metastatic Cancer45 studies
- Prostate Cancer45 studies
- Obesity41 studies
- Lung Cancer41 studies
- Ovarian Cancer36 studies
- Stroke34 studies
- Colorectal Cancer33 studies
- Heart Failure31 studies
- Overweight28 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.